Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Show all lipids with this classification Show all lipids assigned to this classification.
Show only primary classification Show only those lipids which have been assigned to this class as the primary classification.
Show only secondary classifications Show only lipids which have this functionality but are not primarily assigned to this class.

Fatty Acyls [FA]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA07010634 SFE 4:1(2E)(3Me)/3:0 3-Methyl-2-butenyl propionate SFE 8:1 C8H14O2 142.099380
LMFA07010634 SFE 4:1(2E)(3Me)/3:0 3-Methyl-2-butenyl propionate SFE 8:1 C8H14O2 142.099380
LMFA07010232 SFE 12:2(5E,7E)/2:0 5E,7E-Dodecadienyl acetate SFE 14:2 C14H24O2 224.177630
LMFA07010232 SFE 12:2(5E,7E)/2:0 5E,7E-Dodecadienyl acetate SFE 14:2 C14H24O2 224.177630
LMFA07010312 SFE 14:1(5Z)/2:0 5Z-Tetradecenyl acetate SFE 16:1 C16H30O2 254.224581
LMFA07010312 SFE 14:1(5Z)/2:0 5Z-Tetradecenyl acetate SFE 16:1 C16H30O2 254.224581
LMFA07010318 SFE 14:2(3Z,5E)/2:0 3Z,5E-Tetradecadienyl acetate SFE 16:2 C16H28O2 252.208930
LMFA07010318 SFE 14:2(3Z,5E)/2:0 3Z,5E-Tetradecadienyl acetate SFE 16:2 C16H28O2 252.208930
LMFA07010236 SFE 12:2(3E,5Z)/2:0 3E,5Z-Dodecadienyl acetate SFE 14:2 C14H24O2 224.177630
LMFA07010236 SFE 12:2(3E,5Z)/2:0 3E,5Z-Dodecadienyl acetate SFE 14:2 C14H24O2 224.177630
LMFA01030692 8,11,14-Eicosatriynoic acid 8,11,14-Eicosatriynoic acid FA 20:6 C20H28O2 300.208930
LMFA01030381 ETrE(5Z,8Z,11Z) 5Z,8Z,11Z-eicosatrienoic acid FA 20:3 C20H34O2 306.255881
LMFA01020226 19-methyl-5Z,9Z-eicosadienoic acid 19-methyl-5Z,9Z-eicosadienoic acid FA 21:2 C21H38O2 322.287181
LMFA01020226 19-methyl-5Z,9Z-eicosadienoic acid 19-methyl-5Z,9Z-eicosadienoic acid FA 21:2 C21H38O2 322.287181
LMFA03010105 15-methyl-15R-PGD2 9S,15R-dihydroxy-11-oxo-15-methyl-5Z,13E-prostadienoic acid FA 21:4;O3 C21H34O5 366.240626
LMFA01020289 Neopalmitic acid 13,13-dimethyl-tetradecanoic acid FA 16:0 C16H32O2 256.240231
LMFA08020450 Chaetomadramine A N-alpha-palmitoyl-N-delta-anhydromevalonyl-Nδ-hydroxy-omithine C27H50N2O6 498.366888
LMFA08020451 Chaetomadramine B N-alpha-palmitoyl-N-delta-anhydromevalonyl-Nδ-hydroxy-omithine methyl ester C28H52N2O6 512.382538
LMFA08020452 Chaetomadramine D N-alpha-myristoyl-N-delta-anhydromevalonyl-Nδ-hydroxy-omithine methyl ester C26H48N2O6 484.351238
LMFA08020453 Chaetomadramine C N-alpha-myristoyl-N-delta-anhydromevalonyl-Nδ-hydroxy-omithine C25H46N2O6 470.335588
LMFA08020454 Chaetomadramine E N-alpha-trans-palmitoleoyl-N-delta-anhydromevalonyl-Ndelta-hydroxy-omithine C27H48N2O6 496.351238
LMFA07050312 cyclohexane-1-carbonyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-4-{[3-({2-[(cyclohexane-1-carbonyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 7:1 C28H46N7O17P3S 877.188374
LMFA07050312 cyclohexane-1-carbonyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-4-{[3-({2-[(cyclohexane-1-carbonyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 7:1 C28H46N7O17P3S 877.188374
LMFA03010068 11-deoxy-PGF1a 9S,15S-dihydroxy-13E-prostaenoic acid FA 20:2;O2 C20H36O4 340.261361
LMFA03010054 11-deoxy-PGE1 9-oxo-15S-hydroxy-13E-prostaenoic acid FA 20:3;O2 C20H34O4 338.245711
LMFA03010070 11-deoxy-PGF1b 9R,15S-dihydroxy-13E-prostaenoic acid FA 20:2;O2 C20H36O4 340.261361
LMFA13000008 Lanceolitol B1 D-myo-inositol-2-O-dodecanoyl-1-O-beta-D-glucopyranoside C24H44O12 524.283281
LMFA07010381 SFE 17:0/2:0 Heptadecyl acetate SFE 19:0 C19H38O2 298.287181
LMFA13000009 Lanceolitol B2 D-myo-inositol-2-O-tetradecanoyl-1-O-beta-D-glucopyranoside C26H48O12 552.314581
LMFA06000164 9Z-Dodecenal 9Z-Dodecenal FAL 12:1 C12H22O 182.167065
LMFA11000107 9Z-Hentriacontene 9Z-Hentriacontene C31H62 434.485151
LMFA01030771 trans-tetradec-11-enoic acid 11E-tetradecenoic acid FA 14:1 C14H26O2 226.193280
LMFA06000142 4R,8S-Dimethyldecanal 4R,8S-Dimethyldecanal FAL 12:0 C12H24O 184.182715
LMFA13000001 Lanceolitol A1 D-myo-inositol-2-O-dodecanoyl-1-O-beta-D-xylopyranoside C23H42O11 494.272716
LMFA13000002 Lanceolitol A2 D-myo-inositol-2-O-tetradecanoyl-1-O-beta-D-xylopyranoside C25H46O11 522.304016
LMFA13000003 Lanceolitol A3 D-myo-inositol-2-O-14-methylpentadecanoyl-1-O-beta-D-xylopyranoside C27H50O11 550.335316
LMFA13000004 Lanceolitol A4 D-myo-inositol-2-O-10-methylpentadecanoyl-1-O-beta-D-xylopyranoside C27H50O11 550.335316
LMFA13000005 Lanceolitol A5 D-myo-inositol-2-O-9-methylheptadecanoyl-1-O-beta-D-xylopyranoside C29H54O11 578.366616
LMFA13000006 Lanceolitol A6 D-myo-inositol-2-O-16-methylheptadecanoyl-1-O-beta-D-xylopyranoside C29H54O11 578.366616
LMFA13000007 Lanceolitol A7 D-myo-inositol-2-O-eicosanoyl-1-O-beta-D-xylopyranoside C31H58O11 606.397916
LMFA13000010 Lanceolitol B3 D-myo-inositol-2-O-14-methylpentadecanoyl-1-O-beta-D-glucopyranoside C28H52O12 580.345881
LMFA13000011 Lanceolitol B4 D-myo-inositol-2-O-10-methylpentadecanoyl-1-O-beta-D-glucopyranoside C28H52O12 580.345881
LMFA13000012 Lanceolitol B5 D-myo-inositol-2-O-9-methylheptadecanoyl-1-O-beta-D-glucopyranoside C30H56O12 608.377181
LMFA13000013 Lanceolitol B6 D-myo-inositol-2-O-16-methylheptadecanoyl-1-O-beta-D-glucopyranoside C30H56O12 608.377181
LMFA13000014 Lanceolitol B7 D-myo-inositol-2-O-eicosanoyl-1-O-beta-D-glucopyranoside C32H60O12 636.408481
LMFA03080028 (+/-)14,15-EpETrE-d11 14,15-epoxy-5Z,8Z,11Z-eicosatrienoic-16,16,17,17,18,18,19,19,20,20,20-d11 acid C20H21D11O3 331.304190
LMFA03080028 (+/-)14,15-EpETrE-d11 14,15-epoxy-5Z,8Z,11Z-eicosatrienoic-16,16,17,17,18,18,19,19,20,20,20-d11 acid C20H21D11O3 331.304190
LMFA03080028 (+/-)14,15-EpETrE-d11 14,15-epoxy-5Z,8Z,11Z-eicosatrienoic-16,16,17,17,18,18,19,19,20,20,20-d11 acid C20H21D11O3 331.304190
LMFA04040008 17(R)-Neuroprotectin D1 10R,17R-dihydroxy-4Z,7Z,11E,13E,15Z,19Z-docosahexaenoic acid FA 22:6;O2 C22H32O4 360.230061
LMFA04040008 17(R)-Neuroprotectin D1 10R,17R-dihydroxy-4Z,7Z,11E,13E,15Z,19Z-docosahexaenoic acid FA 22:6;O2 C22H32O4 360.230061